Skip to main content
. 2019 Aug 16;18:232–244. doi: 10.1016/j.omtn.2019.08.010

Figure 7.

Figure 7

Mechanism of hMSC-Derived Exo-miR-143 as a Potential Treatment for Prostate Cancer

miR-143 was poorly expressed in PC-3 cells while TFF3 was highly expressed. miR-143 can inhibit the proliferation, migration, and invasion and promote apoptosis in prostate cancer cells by negatively mediating the expression of the TFF3 gene. Thus, hMSC-derived Exo-miR-143 could be a potential treatment for prostate cancer.